You are currently viewing a new version of our website. To view the old version click .

Hematology Reports, Volume 15, Issue 3

September 2023 - 16 articles

Cover Story: Patients with polycythaemia vera (PV) are at an increased risk of thrombosis and haemorrhages. Although hydroxyurea (HU) has been the frontline therapy for patients at high risk of vascular complications, about 25% of patients develop resistance/intolerance to this therapy.  HU resistance/intolerance was defined according to adjusted European LeukemiaNet (ELN) criteria. Overall, 75.9% of patients met at least one of the adjusted ELN criteria for HU resistance, and 14.4% of patients remained on HU throughout the study. The results from this real-world study may help identify the subset of patients at a higher risk for disease sequelae who may benefit from earlier second-line treatment. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (16)

  • Article
  • Open Access
4 Citations
3,097 Views
11 Pages

Real-World Clinical Characterisation of Polycythaemia Vera Patients from a Prospective Registry in Portugal: Is Resistance to Hydroxyurea a Reality?

  • Maria Sarmento,
  • Marta Duarte,
  • Sandra Ponte,
  • Juan Sanchez,
  • Diana Roriz,
  • Laura Fernandes,
  • Maria José Monteiro Silva,
  • Judite Pacheco,
  • Gisela Ferreira and
  • Jorge Freitas
  • + 2 authors

13 September 2023

Patients with polycythaemia vera (PV) are at increased risk of thrombosis and haemorrhages. Although hydroxyurea (HU) has been the frontline therapy for patients at high risk of vascular complications, about 25% of patients develop resistance/intoler...

  • Case Report
  • Open Access
2 Citations
3,116 Views
8 Pages

Diffuse Large B-Cell Lymphoma of the Frontal Sinus: A Case Report

  • Anastasia Urbanelli,
  • Francesca Testi,
  • Giuseppe Riva and
  • Giancarlo Pecorari

12 September 2023

Diffuse large B-cell lymphoma (DLBCL) is the most common type of Non-Hodgkin Lymphoma (NHL). It often involves the gastrointestinal tract, head and neck, and skin, but virtually any tissue or organ can be affected. The primary NHL of the nasal cavity...

  • Case Report
  • Open Access
5 Citations
2,947 Views
6 Pages

Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag

  • Mahmoud Abdelsamia,
  • Saira Farid,
  • Steven Dean and
  • Spero R. Cataland

12 September 2023

Avatrombopag is a novel oral non-peptide thrombopoietin receptor agonist (TPO-RA) that was approved by the FDA as a second-line therapy for chronic immune thrombocytopenia (cITP). Avatrombopag has shown promising results in regards to efficacy and to...

  • Case Report
  • Open Access
2 Citations
4,241 Views
5 Pages

1 September 2023

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT), is a rare and aggressive variant of primary cutaneous lymphoma that typically expresses B cells as well as MUM1/IRF4, BCL2, and FOXP1, whereas BCL6 may be present or undetectable...

  • Article
  • Open Access
1 Citations
2,306 Views
10 Pages

1 September 2023

COVID-19 and other infectious diseases can exacerbate the course of paroxysmal nocturnal hemoglobinuria (PNH). The efficacy and safety of the Gam-COVID-Vac vaccine in patients with PNH has not been adequately studied. A retrospective, observational,...

  • Review
  • Open Access
14 Citations
8,530 Views
12 Pages

Oral Manifestations: A Warning-Sign in Children with Hematological Disease Acute Lymphocytic Leukemia

  • Sandra Clara Soares,
  • Louis J. D. Roux,
  • Ana Rita Castro,
  • Cristina Cardoso Silva,
  • Rita Rodrigues,
  • Viviana M. P. Macho,
  • Fátima Silva and
  • Céu Costa

24 August 2023

Acute lymphocytic leukemia (ALL) is the most frequent form of all childhood leukemias, mostly affecting children between 2 and 4 years old. Oral symptoms, such as mouth ulcers, mucositis, xerostomia, Herpes or Candidiasis, gingival enlargement and bl...

  • Case Report
  • Open Access
1 Citations
2,133 Views
8 Pages

Concomitant Presence of Hb Agrinio and - -Med Deletion in a Greek Male Patient with Hemoglobinopathy H: More Severe Phenotype and Literature Review

  • Michael D. Diamantidis,
  • Stefania Pitsava,
  • Omar Zayed,
  • Ioanna Argyrakouli,
  • Konstantinos Karapiperis,
  • Christos Chatzoulis,
  • Evangelos Alexiou,
  • Achilles Manafas,
  • Evangelos Tsangalas and
  • Konstantinos Karakoussis

8 August 2023

Hemoglobin (Hb) Agrinio is a rare non-deletional a-globin mutation observed almost exclusively in Greek, Spanish or other Mediterranean families. The clinical manifestations of a carrier of a single Hb Agrinio mutation (single heterozygosity) depend...

  • Opinion
  • Open Access
1 Citations
2,490 Views
9 Pages

4 August 2023

Quantitative abdominal adipose tissue analysis is important for obtaining information about prognosis and clinical outcomes on a wide array of diseases. In recent years, the effects of abdominal adipose tissue compartments in patients with lymphoma a...

  • Brief Report
  • Open Access
4 Citations
2,365 Views
9 Pages

2 August 2023

Background and Objectives: Relapsed/refractory extramedullary myeloma (RREMM) is an uncommon and aggressive subtype of multiple myeloma defined by plasma cell proliferation outside the bone marrow. Therapeutic options for RREMM are limited, and the p...

  • Review
  • Open Access
8 Citations
5,138 Views
11 Pages

How I Manage Chronic Lymphocytic Leukemia

  • Patrice Nasnas,
  • Claudio Cerchione,
  • Gerardo Musuraca,
  • Giovanni Martinelli and
  • Alessandra Ferrajoli

1 August 2023

Chronic lymphocytic leukemia (CLL), is a hematologic malignancy characterized by the uncontrolled proliferation of mature B lymphocytes. CLL is the most prevalent leukemia in Western countries. Its presentation can range from asymptomatic with the in...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Hematol. Rep. - ISSN 2038-8330